AOLS

 
Common Stock SEC Reporting - Current
OTCQB
Contact Info
  • 26361 Crown Valley Parkway
  • Suite 150
  • Mission Viejo, CA 92691

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-Q
CIK 0001261734
Fiscal Year End 9/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees 4 a/o Nov 20, 2015
Company Officers/Contacts
David Charles Cavalier CFO, COO, IR
John L. McManus CEO
Company Directors
David Charles Cavalier Chairman
John Clerici
John Farah
Mitchell Kaye
Amit Kumar
Chris Rallis
Jeffrey Scott
Service Providers
Accounting/Auditing Firm
Haskell & White LLP
300 Spectrum Drive
Suite 300
Irvine, CA, 92618
United States
 
Securities Counsel
Drinker, Biddle & Reath LLC
One Logan Square, Suite 2000,
Suite 2000
Philadelphia, PA, 19103
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Incara Pharmaceuticals Corp. until 7-04
  • Formerly=Intercardia, Inc. until 7-99
AOLS Security Details
Share Structure
Market Value1 $29,808,822 a/o Feb 17, 2017
Authorized Shares 200,000,000 a/o Sep 30, 2016
Outstanding Shares 152,085,825 a/o Dec 20, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 53,784,744 a/o May 16, 2016
Par Value 0.001
Shareholders
Shareholders of Record 125 a/o Dec 20, 2016
Short Selling Data
Short Interest 13,313 (35.35%)
Jan 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security